Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Trafficking protein particle complex subunit 6B (TRAPPC6B) is a small protein component of the TRAPP (trafficking protein particle) complex that facilitates vesicle tethering and intracellular membrane trafficking, particularly in the endoplasmic reticulum to Golgi apparatus transport pathway. TRAPPC6B is notably involved in early neural development, influencing differentiation and survival of neurons, potentially through effects on intracellular calcium signaling. Mutations in TRAPPC6B are linked to a rare autosomal recessive neurodevelopmental disorder characterized by microcephaly, severe developmental delays, and epilepsy, with notable brain atrophy observed in affected individuals. TRAPPC6B belongs to the TRAPP small subunits family (BET3 subfamily), and is ubiquitously expressed, with higher predominance in neural tissues. There are currently no approved drugs targeting this protein, nor is it classified as a conventional therapeutic target.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Trafficking protein particle complex subunit 6B (TRAPPC6B).